These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 11272667)
1. Is brachytherapy comparable with radical prostatectomy and external-beam radiation for clinically localized prostate cancer? Merrick GS; Butler WM; Lief JH; Dorsey AT Tech Urol; 2001 Mar; 7(1):12-9. PubMed ID: 11272667 [TBL] [Abstract][Full Text] [Related]
2. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. Nieder AM; Porter MP; Soloway MS J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517 [TBL] [Abstract][Full Text] [Related]
3. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow. Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849 [TBL] [Abstract][Full Text] [Related]
4. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305 [TBL] [Abstract][Full Text] [Related]
5. Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. Merrick GS; Wallner KE; Butler WM J Urol; 2003 May; 169(5):1643-52. PubMed ID: 12686802 [TBL] [Abstract][Full Text] [Related]
6. Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. Eggener SE; Roehl KA; Yossepowitch O; Catalona WJ J Urol; 2006 Oct; 176(4 Pt 1):1399-403. PubMed ID: 16952643 [TBL] [Abstract][Full Text] [Related]
7. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. D'Amico AV; Whittington R; Malkowicz SB; Cote K; Loffredo M; Schultz D; Chen MH; Tomaszewski JE; Renshaw AA; Wein A; Richie JP Cancer; 2002 Jul; 95(2):281-6. PubMed ID: 12124827 [TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F; Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680 [TBL] [Abstract][Full Text] [Related]
9. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate. Walsh PC J Urol; 2000 Jun; 163(6):1802-7. PubMed ID: 10799186 [TBL] [Abstract][Full Text] [Related]
10. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE. Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR; J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425 [TBL] [Abstract][Full Text] [Related]
11. Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer. D'Amico AV; Hui-Chen M; Renshaw AA; Sussman B; Roehl KA; Catalona WJ J Urol; 2006 Dec; 176(6 Pt 2):S11-5. PubMed ID: 17084157 [TBL] [Abstract][Full Text] [Related]
12. Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005. Colberg JW; Decker RH; Khan AM; McKeon A; Wilson LD; Peschel RE Cancer J; 2007; 13(4):229-32. PubMed ID: 17762756 [TBL] [Abstract][Full Text] [Related]
13. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568 [TBL] [Abstract][Full Text] [Related]
14. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Demanes DJ; Rodriguez RR; Schour L; Brandt D; Altieri G Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1306-16. PubMed ID: 15817332 [TBL] [Abstract][Full Text] [Related]
15. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
16. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy. Lee HK; Adams MT; Motta J Brachytherapy; 2008; 7(1):17-21. PubMed ID: 18201939 [TBL] [Abstract][Full Text] [Related]
17. Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE. Litwin MS; Sadetsky N; Pasta DJ; Lubeck DP J Urol; 2004 Aug; 172(2):515-9. PubMed ID: 15247718 [TBL] [Abstract][Full Text] [Related]